| Matthew M Brigmon, MD | |
|
8300 Floyd Curl Dr, San Antonio, TX 78229-3931 | |
| (210) 450-9800 | |
| (210) 450-6018 |
| Full Name | Matthew M Brigmon |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 8300 Floyd Curl Dr, San Antonio, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013320332 | NPI | - | NPPES |
| Entity Name | University Of Texas Health Science Center At San Antonio |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720051717 PECOS PAC ID: 0042128548 Enrollment ID: O20040607000664 |
News Archive
Examining data from the first six weeks of their landmark DETECT study, a team of scientists from the Scripps Research Translational Institute sees encouraging signs that wearable fitness devices can improve public health efforts to control COVID-19.
The Massachusetts Commonwealth Health Insurance Connector, which is tasked under the state's new health insurance law with determining what premiums are affordable for low-income state residents, is proposing that the state's lower-income uninsured residents spend up to 6.6% of their income to purchase health coverage, the Boston Globe reports.
Nanoparticles with a wide range of applying, including medicine, damage cells of microalgae Heterosigma akashivo badly. This algae species is widely spread in the Russian Far East marine area. The acute toxic effect exhibited at concentrations of 100 mg/l of carbon nanotubes and silicon nanotubes in the sea- or fresh water.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
› Verified 2 days ago
| Entity Name | Gulf Coast Intensivists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104509199 PECOS PAC ID: 2264896364 Enrollment ID: O20230907002726 |
News Archive
Examining data from the first six weeks of their landmark DETECT study, a team of scientists from the Scripps Research Translational Institute sees encouraging signs that wearable fitness devices can improve public health efforts to control COVID-19.
The Massachusetts Commonwealth Health Insurance Connector, which is tasked under the state's new health insurance law with determining what premiums are affordable for low-income state residents, is proposing that the state's lower-income uninsured residents spend up to 6.6% of their income to purchase health coverage, the Boston Globe reports.
Nanoparticles with a wide range of applying, including medicine, damage cells of microalgae Heterosigma akashivo badly. This algae species is widely spread in the Russian Far East marine area. The acute toxic effect exhibited at concentrations of 100 mg/l of carbon nanotubes and silicon nanotubes in the sea- or fresh water.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew M Brigmon, MD 8300 Floyd Curl Dr, San Antonio, TX 78229-3931 Ph: (210) 450-9800 | Matthew M Brigmon, MD 8300 Floyd Curl Dr, San Antonio, TX 78229-3931 Ph: (210) 450-9800 |
News Archive
Examining data from the first six weeks of their landmark DETECT study, a team of scientists from the Scripps Research Translational Institute sees encouraging signs that wearable fitness devices can improve public health efforts to control COVID-19.
The Massachusetts Commonwealth Health Insurance Connector, which is tasked under the state's new health insurance law with determining what premiums are affordable for low-income state residents, is proposing that the state's lower-income uninsured residents spend up to 6.6% of their income to purchase health coverage, the Boston Globe reports.
Nanoparticles with a wide range of applying, including medicine, damage cells of microalgae Heterosigma akashivo badly. This algae species is widely spread in the Russian Far East marine area. The acute toxic effect exhibited at concentrations of 100 mg/l of carbon nanotubes and silicon nanotubes in the sea- or fresh water.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that pursuant to the Federal Acquisition Regulations and pending a ruling in a protest recently filed by a competitor the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), has suspended work under the modification the Company announced on February 23, 2010 to its existing contract with BARDA for the research and development of SparVax™. June 11, 2010 is the deadline to rule on the protest.
› Verified 2 days ago
Dr. Dennis Anthony Ruff, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 8307 Gault Ln, San Antonio, TX 78209 Phone: 210-798-5112 | |
Zarema J Singson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5223 Hamilton Wolfe Rd, San Antonio, TX 78229 Phone: 210-614-1234 Fax: 210-614-0952 | |
Sapna Raghunathan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8300 Floyd Curl Dr, San Antonio, TX 78229 Phone: 210-450-9490 Fax: 210-450-6065 | |
Dr. Jonathan Edward Slovik, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 Fax: 210-358-0647 | |
Mr. Paul Joseph Fanucchi, NP Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: Marianist Residence, 520 Fondham, San Antonio, TX 78228 Phone: 210-434-4157 Fax: 210-433-6005 | |
Socrates B Aramburu, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1100 Mccullough Ave, Suite 300, San Antonio, TX 78212 Phone: 210-271-3204 Fax: 210-222-2761 | |
David H White, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6800 Ih 10 W, Ste 350, San Antonio, TX 78201 Phone: 210-616-0801 |